EyePoint (EYPT) vs Standard BioTools (LAB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Standard BioTools (LAB) has outperformed EyePoint (EYPT) over the past year, losing 47.8% versus a loss of 74.9%. Over five years, EYPT leads with a -71.0% price change compared with -87.3% for LAB. EyePoint is the larger company by market cap ($278.4 million vs $266.4 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | EYPT | LAB |
|---|---|---|
| Share price | $3.32 | $0.6787 |
| Market cap | $278.35M | $266.44M |
| 1-day change | +4.73% | -6.00% |
| YTD return | -81.83% | -46.98% |
| 1-year return | -74.94% | -47.79% |
| 5-year return | -70.98% | -87.29% |
| EPS (TTM) | $-3.93 | $-0.12 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $19.11 | $1.72 |
| 52-week low | $3.05 | $0.63 |
| Distance from 52-week high | -82.63% | -60.54% |
| Analyst consensus | none | none |
| Avg. price target upside | +680.42% | +98.91% |
| Average volume | 3.95M | 1.57M |
| Shares outstanding | 83.84M | 392.58M |
| Employees | 214 | 385 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- LAB has outperformed EYPT by 27.2 percentage points over the past year.
About EyePoint
EYPT stock →EyePoint, Inc. engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases.
Healthcare · Biotechnology · 214 employees
About Standard BioTools
LAB stock →Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific. The company operates through Proteomics and Genomics segments.
Healthcare · Medical Devices · 385 employees
EYPT vs LAB FAQ
Which is bigger, EyePoint or Standard BioTools?
EyePoint (EYPT) is larger, with a market capitalization of $278.35M compared with $266.44M for Standard BioTools (LAB).
Which stock has performed better over the past year, EYPT or LAB?
LAB returned -47.79% over the past 12 months, compared with -74.94% for EYPT (price return, excluding dividends). Past performance does not predict future results.
Are EyePoint and Standard BioTools in the same industry?
Both are in the Healthcare sector, but in different industries: Biotechnology for EyePoint and Medical Devices for Standard BioTools.